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.M.  Katoch
epartment of Health Research, Indian Council of Medical Research, New Delhi, IndiaIn public health, success in controlling, eliminating, or eradicat-
ng a disease depends on availability of good quality surveillance
ata at the national level. A problem cannot be addressed until it is
easured systematically. With regard to the vaccine-preventable
iseases, surveillance activities are critical to detect and reliably
easure to provide data to deﬁne the epidemiology of a disease,
dentify circulating strains or serotypes/genotypes, monitor disease
rends and to assess whether an intervention such as a vaccine is
ecessary. If a decision to introduce vaccine is to be made then
here is need to have continued surveillance to demonstrate effec-
iveness, and efﬁcacy of vaccine against various strains or different
isease severity, to demonstrate a decrease in vaccine preventable
isease in vaccinated individuals as well as to know whether there
s any herd immunity [1–3].
In the past, several studies were conducted by investigators
cross India on the etiology of diarrheal disease, especially due
o rotavirus, in children less than 5 years of age. These studies
ave fragmented information, due to differences in study popu-
ations, design of the studies, recruitment strategies and the tests
mployed. The results of these studies were not directly compa-
able. It is estimated that globally nearly half a million deaths are
ttributable to rotavirus diarrhea each year with majority of deaths
ccurring in sub-Saharan Africa and South Asia. Over 20% of these
eaths are estimated to occur in India alone [4]. By age of 5 years,
lmost every child will have been infected by rotavirus. Therefore,
n 2005 with the aim of systematically collection of data and to have
 sustainable surveillance program, the Indian Council for Medical
esearch (ICMR) in collaboration with Centers for Disease Control
nd Prevention (CDC) in Atlanta, USA, established a network for
ospital based surveillance of rotavirus in different parts of the
ountry.
The goals of the Indian Rotavirus Strain Surveillance Network
ere to generate timely and geographically representative infor-
ation on the clinical, epidemiological, and virological features ofevere rotavirus disease in Indian children, with use of standardized
rotocols for enrollment and diagnostic evaluation. The network
ad four laboratories and ten hospitals in seven different regions
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senting with acute gastroenteritis and requiring hospitalization for
rehydration for at least 6 h were enrolled. A fecal specimen was
obtained and tested for rotavirus using a commercial enzyme
immunoassay, and strains were characterized using RT-PCR.
Between December 2005 and June 2009, a total of 7285 stool
specimens collected were tested for rotavirus, among which 2899
(40%) were positive for rotavirus. The common G-types were
G1 (25%), G2 (21%), G9 (13%), and G12 (10%). The proportion
of rotavirus infections attributed to G12 infections rose from
8% to 39% in the Northern region and from 8% to 24% in the
Western region [5]. The network highlighted the high, ongoing
burden of rotavirus disease in India, with circulation of a wide
range of rotavirus strains including several uncommon strains,
including an increasing detection of G12 rotavirus strains in some
regions [6].
An additional component within the network was  evaluation
of the cost of treatment of gastroenteritis at eight governmen-
tal and non-governmental facilities in four cities. Questionnaires
detailing healthcare utilization, medical and non-medical expen-
diture, and lost income were completed by families of children
<5 yrs of age hospitalized for gastroenteritis. Data on direct costs
alone from multiple facilities show that diarrheal disease consti-
tutes a large economic burden on Indian families. The median
cost of a diarrheal episode based on annual household expen-
diture was 6.4% for all-cause diarrhea and 7.6% for rotavirus
diarrhea [7].
Based on these important data, collected at a time when there
was either no licensed vaccine available in India, or when there
was limited uptake in the private sector, a decision was made in
2012 to expand and extend the rotavirus surveillance network to
ensure more representative data from other parts of the country.
The network now includes 30 clinical recruitment sites or hospitals,
eight regional laboratories and four referral laboratories located in
different parts of India, including high-mortality burden states such
as Bihar and Odisha (Fig. 2).The goal of the network is not only to collect more data but also
to establish a model surveillance system for a vaccine preventable
disease based on which further studies to evaluate the impact
of vaccination can be conducted. There are several steps being
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Fig. 1. Indian Rotavirus Surveillance Network sites which recruited children <5
years of age hospitalized with acute gastroenteritis between 2005 and 2009
Fig. 2. Current and planned National Rotavirus Surveillance Network sites recruiting
children <5 years of age hospitalized with acute gastroenteritis.
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undertaken to enhance the quality of the surveillance system and
these include
i)  providing training to clinical and laboratory staff and written
guidance using jointly developed standard operating proce-
dures,
ii) standardizing reporting in a simple case report form,
iii) ensuring adequate clinical information by monitoring and
feedback,
iv) obtaining and testing appropriate laboratory specimens by
standardized methods,
v) ensuring access to referral laboratories,
vi) developing an external quality assessment program,
vii) providing frequent (scheduled monthly and quarterly) reports
and relevant feedback, through monitoring by an Expert
committee, ICMR Headquarters and National Institute of Epi-
demiology (NIE),
viii) promoting awareness among pediatricians and other health-
care staff through participation in surveillance activities and
dissemination of information.
Going forward, the use of the rotavirus surveillance network
established by ICMR will need to reﬂect the priorities of the govern-
ment of India. The network has already yielded results in estimating
the burden of disease and its seasonal variation. The network is also
a readily available platform to inform decision-makers for vaccine
introduction into the immunization programme and for further
studies to monitor the impact of vaccine. While broad heterotypic
protection from rotavirus vaccination is expected based on pre-
and post-licensure data from other settings, effectiveness assess-
ments and rotavirus strain monitoring after vaccine introduction
will continue to be important.
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